ProfileGDS4095 / 220925_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 75% 74% 76% 76% 75% 77% 77% 77% 75% 76% 76% 76% 75% 75% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.8944875
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.6941974
GSM709765LY2 SRC1-siRNA untreated rep38.0275276
GSM709771LY2 SRC1-siRNA untreated rep17.9368776
GSM709772LY2 SRC1-siRNA untreated rep27.87575
GSM709775LY2 SRC1-siRNA untreated rep48.1670177
GSM709764LY2 control-siRNA tamoxifen treated rep28.1967677
GSM709766LY2 control-siRNA tamoxifen treated rep38.173777
GSM709768LY2 control-siRNA tamoxifen treated rep17.8781575
GSM709777LY2 control-siRNA tamoxifen treated rep48.1076476
GSM709770LY2 control-siRNA untreated rep37.9814276
GSM709773LY2 control-siRNA untreated rep18.0560276
GSM709774LY2 control-siRNA untreated rep27.8613775
GSM709776LY2 control-siRNA untreated rep47.7921275